Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists

被引：26

作者：

Galatsis, Paul ^{[1
]}

Yamagata, Koji ^{[1
]}

Wendt, John A. ^{[1
]}

Connolly, Cleo J. ^{[1
]}

Mickelson, John W. ^{[1
]}

Milbank, Jared B. J. ^{[1
]}

Bove, Susan E. ^{[2
,3
]}

Knauer, Christopher S. ^{[2
,3
]}

Brooker, Rachel M. ^{[2
,3
]}

Augelli-Szafran, Corinne E. ^{[1
]}

Schwarz, Roy D. ^{[2
,3
]}

Kinsora, Jack J. ^{[2
,3
]}

Kilgore, Kenneth S. ^{[2
,3
]}

机构：

[1] Pfizer Global REs & Dev, Dept Med Chem, Ann Arbor, MI 48105 USA

[2] Pfizer Global REs & Dev, Dept CNS Biol, Ann Arbor, MI 48105 USA

[3] Pfizer Global REs & Dev, Dept Inflammat, Ann Arbor, MI 48105 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 23期

关键词：

mGlu5; receptor; antagonist; 1,5-naphthyridine; 1,6-naphthyridine; 1,8-naphthyridine; rat; osteoarthritis; pain;

D O I：

10.1016/j.bmcl.2007.09.083

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We describe three novel regioisomeric series of aryl naphthyridine analogs, which are potent antagonists of the Class III GPCR mGlu5 receptor. The synthesis and in vitro and in vivo pharmacological activities of these analogs are discussed. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：6525 / 6528

页数：4

共 19 条

[1] Functionalization at position 3 of the phenyl ring of the potent mGluR5 noncompetitive antagonists MPEP [J].

Alagille, D ;

Baldwin, RM ;

Roth, BL ;

Wroblewski, JT ;

Grajkowska, E ;

Tamagnan, GD .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (04) :945-949

[2] Synthesis and receptor assay of aromatic-ethynyl-aromatic derivatives with potent mGluR5 antagonist activity [J].

Alagille, D ;

Baldwin, RM ;

Roth, BL ;

Wroblewski, JT ;

Grajkowska, E ;

Tamagnan, GD .

BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (01) :197-209

[3] Metabotropic glutamate receptors: Agonists, antagonists and allosteric modulators [J].

Augelli-Szafran, CE ;

Schwarz, RD .

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38, 2003, 38 :21-30

[4] Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications [J].

Bach, Peter ;

Issac, Methvin ;

Slassi, Abdelmalik .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (04) :371-384

[5] A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5) [J].

Bach, Peter ;

Nilsson, Karolina ;

Wallberg, Andreas ;

Bauer, Udo ;

Hammerland, Lance G. ;

Peterson, Alecia ;

Svensson, Tor ;

Osterlund, Krister ;

Karis, David ;

Boije, Maria ;

Wensbo, David .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) :4792-4795

[6] Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5) [J].

Bach, Peter ;

Nilsson, Karolina ;

Svensson, Tor ;

Bauer, Udo ;

Harnmerland, Lance G. ;

Peterson, Alecia ;

Wallberg, Andreas ;

Osterlund, Krister ;

Karis, David ;

Boije, Maria ;

Wensbo, David .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) :4788-4791

[7] Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists [J].

Bonnefous, C ;

Vernier, JM ;

Hutchinson, JH ;

Chung, J ;

Reyes-Manalo, G ;

Kamenecka, T .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (04) :1197-1200

[8] Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis [J].

Bove, SE ;

Calcaterra, SL ;

Brooker, RM ;

Huber, CM ;

Guzman, RE ;

Juneau, PL ;

Schrier, DJ ;

Kilgore, KS .

OSTEOARTHRITIS AND CARTILAGE, 2003, 11 (11) :821-830

[9] Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists [J].

Chua, PC ;

Nagasawa, JY ;

Bleicher, LS ;

Munoz, B ;

Schweiger, EJ ;

Tehrani, L ;

Anderson, JJ ;

Cramer, M ;

Chung, J ;

Green, MD ;

King, CD ;

Reyes-Manalo, G ;

Cosford, NDP .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) :4589-4593

[10] Structure-activity relationship of thiopyrimidines as mGluR5 antagonists [J].

Hammerland, LG ;

Johansson, M ;

Malmström, J ;

Mattsson, JP ;

Minidis, ABE ;

Nilsson, K ;

Peterson, A ;

Wensbo, D ;

Wållberg, A ;

Österlund, K .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (09) :2467-2469

← 1 2 →